MORE►
GPG Ventures
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
by Lance Murray |
Oct 10, 2023
Dallas-based venture capital firm GPG Ventures has opened its third Texas office in Austin and added veteran Austin business leader Claire England to lead that office as investment partner.
“We’re thrilled for Claire to open our Austin office and add her executive leadership and investing talent to the GPG Ventures team....
MORE►
by Lance Murray |
Apr 11, 2023
The Coppell-based startup said it will use the proceeds to advance and scale its Digital Medical Home, which includes diagnostic-enabled Virtual Primary Care and Virtual Behavioral Health Solutions tailored to fit the healthcare needs of any population. Recuro integrates advanced science, data, at-home diagnostics, and targeted genomics for cancer screening and pharmacogenomics "to better inform integrated care," the company says.
MORE►
by Jasmin Brand |
Jan 12, 2021
A constellation of North Texas female funders has emerged. They're bringing new perspectives and new deals to the table.
MORE►
